Garner William
Fortune : 12 M $ au 31/05/2026
Fortune : 12 M $ au 31/05/2026
Garner J.
William was the founder of Kintara Therapeutics, Inc. founded in 2009, serving as Independent Director from 2015 to 2016.
Founder of Vaneltix Pharma, Inc. founded in 1997, holding the titles of President, Chief Executive Officer & Director from 1997 to 2010.
Founder of Inverseon, Inc. founded in 2004, acting as Chairman & Chief Executive Officer from 2009 to 2012.
Founder of EGB Ventures LLC founded in 2015, serving as Managing Director since 2015.
Founder of Del Mar Pharmaceuticals (BC) Ltd. founded in 2010, serving as Director from 2010 to 2016.
Founder of Invion Ltd. founded in 2012, holding the titles of Chief Executive Officer & Managing Director from 2012 to 2013.
Founder of Race Oncology Ltd. founded in 2016, acting as Non-Executive Director in 2020.
Founder of ISLA Pharmaceuticals founded in 2017, serving as Non-Executive Director since 2020.
Founder of Tryp Therapeutics, Inc. founded in 2019, acting as Executive Director from 2020 to 2022.
Founder of GeneTether, Inc. founded in 2018, serving as Director since 2018.
Founder of Rize Oncology, Inc. founded in 2018, holding the title of Executive Director from 2018 to 2025.
Dr. William is also the founder of Igxbio, Inc.,Urigen N.A, Inc.,Update Pharma, Inc...
Dr. William currently serves as Director at Innovation Angel Foundation, Inc. Former positions include Chief Executive Officer at Valentis, Inc., Chairman at InMed Pharmaceuticals, Inc. from 2016 to 2022, Head-Medical Affairs at Roche Holding AG, Associate at Paramount Capital, Inc., and Principal at Roche Laboratories, Inc. Education includes a doctorate from New York Medical College and graduate studies at Harvard T.H.
Chan School of Public Health.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Island Pharmaceuticals Ltd.
Island Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops infectious diseases therapeutics 14,09 % | 03/12/2025 | 41 690 073 ( 14,09 % ) | 11 M $ | 31/05/2026 |
RIZE ONCOLOGY INC. 66,91 % | 10/11/2025 | 50 682 204 ( 66,91 % ) | 733 371 $ | 30/04/2025 |
| Sociétés | Poste | Début |
|---|---|---|
EGB Ventures LLC
EGB Ventures LLC Investment ManagersFinance EGB Ventures invests in companies located across the globe. The firm targets companies operating in the fields of pharmaceutical sectors. It participates in early stage capital requirements. | Fondateur | 05/01/2015 |
Update Pharma, Inc.
Update Pharma, Inc. Medical DistributorsDistribution Services Develops and provides anti-cancer drugs and other pharmaceutical products | Fondateur | - |
Innovation Angel Foundation, Inc. | Directeur/Membre du Conseil | - |
ISLA Pharamceuticals
ISLA Pharamceuticals Pharmaceuticals: MajorHealth Technology Develops tropical disease therapies | Fondateur | 01/03/2017 |
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services Develops gene editing technologies intended for human therapeutic applications | Fondateur | 12/02/2018 |
| Sociétés | Poste | Fin |
|---|---|---|
| RIZE ONCOLOGY INC. | Fondateur | 31/10/2025 |
| INMED PHARMACEUTICALS INC. | Président | 15/12/2022 |
Tryp Therapeutics, Inc.
Tryp Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Fondateur | 18/02/2022 |
| RACURA ONCOLOGY LTD | Fondateur | 28/10/2020 |
| ░░░ ░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 22 |
|---|---|
Roche Holding AG
Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Valentis, Inc.
Valentis, Inc. Pharmaceuticals: MajorHealth Technology Develops products for urology indications | Health Technology |
Paramount Capital, Inc. | |
InMed Pharmaceuticals, Inc.
InMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures prescription-based products for dermatology and ocular diseases | Health Technology |
Igxbio, Inc.
Igxbio, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops DNA immunotherapies for HIV infection | Commercial Services |
Kintara Therapeutics, Inc.
Kintara Therapeutics, Inc. BiotechnologyHealth Technology Develops novel cancer therapies | Health Technology |
New York Medical College
New York Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Urigen N.A, Inc.
Urigen N.A, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products for urological disorders | Health Technology |
Vaneltix Pharma, Inc.
Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for patients with urological ailments | Health Technology |
Roche Laboratories, Inc.
Roche Laboratories, Inc. Medical DistributorsDistribution Services Markets and sells pharmaceutical medications | Distribution Services |
Inverseon, Inc.
Inverseon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs for chronic lung diseases | Health Technology |
EGB Ventures LLC
EGB Ventures LLC Investment ManagersFinance EGB Ventures invests in companies located across the globe. The firm targets companies operating in the fields of pharmaceutical sectors. It participates in early stage capital requirements. | Finance |
Del Mar Pharmaceuticals (BC) Ltd.
Del Mar Pharmaceuticals (BC) Ltd. Pharmaceuticals: MajorHealth Technology Provides drug development services | Health Technology |
Harvard T.H. Chan School of Public Health
Harvard T.H. Chan School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Invion Ltd.
Invion Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for chronic lung diseases | Health Technology |
Update Pharma, Inc.
Update Pharma, Inc. Medical DistributorsDistribution Services Develops and provides anti-cancer drugs and other pharmaceutical products | Distribution Services |
Innovation Angel Foundation, Inc. | |
Race Oncology Ltd.
Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
ISLA Pharamceuticals
ISLA Pharamceuticals Pharmaceuticals: MajorHealth Technology Develops tropical disease therapies | Health Technology |
Tryp Therapeutics, Inc.
Tryp Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services Develops gene editing technologies intended for human therapeutic applications | Commercial Services |
GeneTether Therapeutics, Inc.
GeneTether Therapeutics, Inc. BiotechnologyHealth Technology Develops gene editing therapies and platform | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national